Real-time compliance monitoring system for digital therapies and diagnostics

用于数字治疗和诊断的实时合规性监控系统

• 批准号: 566670-2021
• 负责人: Thompson, Benjamin
• 金额: $ 1.09万
• 依托单位: University of Waterloo
• 依托单位国家: 加拿大
• 项目类别: Idea to Innovation
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-01-01 至 2022-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=728717
• 关键词: Real; time; compliance; monitoring; system

The Real Time Adherence Monitoring System for Digital Therapies and Diagnostics provides a novel approach for monitoring a patient's compliance to digital therapies (e.g. treatment of the common vision disorder amblyopia) that takes into account many parameters such as eye gaze, eye blinking, head pose, facial expression, relative eye stability and yawning. It is able to detect whether a patient is wearing the 3D glasses required for treatment and/or ophthalmic prescription during therapy. It can detect whether the patient is performing the therapy or someone else (e.g. a sibling). It also detects seven emotions in real-time, namely: "Happy", "Sad", "Disgust", "Neutral", "Anger", "Surprise" and "Scared". Some advantages of this innovation include: (1) ability to track multiple parameters in real-time. (2) produce feedback signals to regain patient's attention to treatment or alert their parent/caregiver/clinician upon detecting that the patient is upset or unengaged. (3) monitor patient adherence and provide detailed adherence analytics. This innovation has applications in the patient and driver monitoring industries as well as the treatment of vision (e.g. amblyopia) and psychiatric disorders (e.g. ADHD). Digital patient monitoring devices are becoming increasing popular for the treatment of a wide range of disorders, particularly within the context of COVID-19. While technological advancements, prevalence of autonomous vehicles and rise in car accidents have made driver monitoring systems highly valuable for the automotive industry. As part of this Market Assessment grant, the selected consultant (Adventus) will perform a thorough market analysis to identify the most suitable market opportunities along with technical, marketing and financial challenges associated with the application of the technology in a particular market segment. A favorable market assessment result will 1) formulate the commercialization strategy and help attract potential licensees 2) form the basis for submitting a follow-on NSERC I2I Phase 1 project proposal.

数字治疗和诊断的实时依从性监测系统提供了一种新的方法来监测患者对数字治疗的依从性（例如，治疗常见的视力障碍弱视），该系统考虑了许多参数，如眼睛凝视、眼睛眨眼、头部姿势、面部表情、相对眼睛稳定性和打哈欠。它能够检测患者在治疗过程中是否戴着治疗所需的3D眼镜和/或眼科处方。它可以检测患者是否正在进行治疗，或者是其他人（例如兄弟姐妹）。它还能实时检测七种情绪，分别是：“快乐”、“悲伤”、“厌恶”、“中性”、“愤怒”、“惊讶”和“害怕”。这种创新的一些优点包括：(1)能够实时跟踪多个参数。(2)产生反馈信号，使患者重新关注治疗，或在发现患者不安或不投入时提醒其父母/护理人员/临床医生。(3)监测患者依从性并提供详细的依从性分析。这项创新应用于患者和驾驶员监控行业，以及视力（如弱视）和精神疾病（如多动症）的治疗。数字患者监测设备在治疗各种疾病方面越来越受欢迎，特别是在2019冠状病毒病的背景下。随着技术的进步，自动驾驶汽车的普及以及车祸的增加，驾驶员监控系统对汽车行业非常有价值。作为市场评估补助金的一部分，被选中的咨询公司（Adventus）将进行全面的市场分析，以确定最合适的市场机会，以及与特定细分市场中技术应用相关的技术、营销和财务挑战。有利的市场评估结果将有助1)制定商业化策略及吸引潜在持牌人2)为提交后续的NSERC I2I第一期计划建议书奠定基础。